Citation Impact
Citing Papers
A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
2013
Nanoparticles: Properties, applications and toxicities
2017 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
STAT inhibitors for cancer therapy
2013
Microenvironmental regulation of tumour angiogenesis
2017
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Head and neck squamous cell carcinoma
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
2012
Targeting transcription factors by small compounds—Current strategies and future implications
2015
Hepatocellular carcinoma
2016 Standout
Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
2009
Nanotheranostics – a review of recent publications
2012
miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway
2015
Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo
2013
NF-κB and STAT3 – key players in liver inflammation and cancer
2010
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Thymoquinone: Potential cure for inflammatory disorders and cancer
2011 Standout
Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
2011
The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
2015
Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors
2020
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
2012
STAT3 inhibitors for cancer therapy
2013
New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases
2011 StandoutNobel
Medulloblastomics revisited: biological and clinical insights from thousands of patients
2019
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
Cancer-associated cachexia
2018 Standout
STAT3 SIGNALING: Anticancer Strategies and Challenges
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
2020
Hitting the right spot: Mechanism of action of OPB‐31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
2015
Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy
2013
Vesicle Formation from an Amphiphilic Porphyrin Derivative at the Air–Water Interface
2010
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
Emerging cytokine networks in colorectal cancer
2015
STAT3 in the systemic inflammation of cancer cachexia
2016
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Nucleic acid-based approaches to STAT inhibition
2012
Ion‐Pair Binding: Is Binding Both Binding Better?
2009
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
2010
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Myocyte signalling in leucocyte recruitment to the heart
2014
Control of Metastasis by NK Cells
2017
Solution-phase counterion effects in supramolecular and mechanostereochemical systems
2010 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
2020
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
STAT signaling in the pathogenesis and treatment of myeloid malignancies
2012
Therapeutic modulators of STAT signalling for human diseases
2013
Liposomes as nanomedical devices
2015 Standout
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
2014
Ion pair receptors
2010
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
2010
Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening
2008
Cancer-related inflammation and treatment effectiveness
2014 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
2013
PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non–Small Cell Lung Cancer
2016
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
A polypyridyl-pyrene based off-on Cd2+ fluorescent sensor for aqueous phase analysis and living cell imaging
2014
Anemia of Chronic Disease
2005 Standout
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
2014 Standout
Bromotyrosine Alkaloids from the Australian Marine Sponge Pseudoceratina verrucosa
2013
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
2012
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
DNA binding and cytotoxicity of fluorescent curcumin-based Zn(ii) complexes
2012
Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein–protein binding
2014
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
2017 StandoutNobel
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
2016
The Mitsunobu reaction in the 21stcentury
2015
The Intracellular Delivery of a Recombinant Peptide Derived from the Acidic Domain of PIAS3 Inhibits STAT3 Transactivation and Induces Tumor Cell Death
2010
Marine natural products
2015 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
Targeting the JAK/STAT pathway in solid tumors
2020
Aggregation‐Induced Emission Features of Organometal Halide Perovskites and Their Fluorescence Probe Applications
2014
Covalent Organic Frameworks: Design, Synthesis, and Functions
2020 Standout
Phosphine Organocatalysis
2018 Standout
Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells
2010
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Artificial Receptors for the Recognition of Phosphorylated Molecules
2011
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
2010
Importance of direct macrophage ‐ Tumor cell interaction on progression of human glioma
2012
Comparative study of porphyrin derivatives in monolayers at the air–water interface and in Langmuir–Blodgett films
2011
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Superparamagnetic Fe3O4 nanoparticles: synthesis by a solvothermal process and functionalization for a magnetic targeted curcumin delivery system
2016
Potent and Selective Phosphopeptide Mimetic Prodrugs Targeted to the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3
2011
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Chemical sensing of water contaminants by a colloid of a fluorescent imine-linked covalent organic framework
2018
The exciton model in molecular spectroscopy
1965 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
2020
Synthesis and spectral properties of novel chlorinated pH fluorescent probes
2010
Brightly Luminescent and Color-Tunable Colloidal CH3NH3PbX3 (X = Br, I, Cl) Quantum Dots: Potential Alternatives for Display Technology
2015 Standout
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Conformationally Constrained Peptidomimetic Inhibitors of Signal Transducer and Activator of Transcription 3: Evaluation and Molecular Modeling
2009
Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications
2016 Standout
A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.
2012
Metal–Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal–Organic Materials
2012 Standout
Loss of STAT3 in murine NK cells enhances NK cell–dependent tumor surveillance
2014
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
A novel small inhibitor, LLL12, targets STAT3 in non‑small cell lung cancer in�vitro and in�vivo
2018
Cyclam-methylbenzimidazole: a Selective OFF-ON Fluorescent Sensor for Zinc
2011
N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a New Scaffold that Provides Rapid Access to Antimicrotubule Agents: Synthesis and Evaluation of Antiproliferative Activity Against Select Cancer Cell Lines
2010
Works of Patrick T. Gunning being referenced
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
2016
Changes in Signal Transducer and Activator of Transcription 3 (STAT3) Dynamics Induced by Complexation with Pharmacological Inhibitors of Src Homology 2 (SH2) Domain Dimerization
2014
CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence
2016
A Photostable, pH-Invariant Fluorescein Derivative for Single-Molecule Microscopy
2009
Positive ion pair cooperativity exhibited for the binding of phosphate under physiological conditions
2005
Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein
2008
A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes
2010
Artificially Induced Protein–Membrane Anchorage with Cholesterol‐Based Recognition Agents as a New Therapeutic Concept
2011
Signal transducer and activator of transcription 3 inhibitors: a patent review
2010
Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities
2009
Targeting Protein–Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small‐Molecule, Nonpeptidic SH2 Domain Binders
2008
A STAT inhibitor patent review: progress since 2011
2015
Progress towards the development of SH2 domain inhibitors
2013
An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery
2011
A modular ditopic crown-shielded phosphate ion-pair receptor
2004
Inhibiting aberrant Stat3 function with molecular therapeutics
2010
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
2011
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
2018
Coordination complex SH2 domain proteomimetics: an alternative approach to disrupting oncogenic protein–protein interactions
2009
Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein
2010
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: Structural recognition of STAT SH2 domains
2007
Inhibitors of Stat5 protein signalling
2011
An Oxazole-Based Small-Molecule Stat3 Inhibitor Modulates Stat3 Stability and Processing and Induces Antitumor Cell Effects
2007
STAT3 activity is necessary and sufficient for the development of immune‐mediated myocarditis in mice and promotes progression to dilated cardiomyopathy
2013
Mild, efficient and rapid O-debenzylation of ortho-substituted phenols with trifluoroacetic acid
2008
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
2013
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
2009
Synthesis and Binding Properties of Hybrid Cyclophane−Azamacrocyclic Receptors
2004
Facile and efficient access to 2,6,9-tri-substituted purines through sequential N9, N2 Mitsunobu reactions
2009
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
2012
Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity
2011
An Excimer-Based, Turn-On Fluorescent Sensor for the Selective Detection of Diphosphorylated Proteins in Aqueous Solution and Polyacrylamide Gels
2014
Recent advances in biosensory and medicinal therapeutic applications of zinc(II) and copper(II) coordination complexes
2010
Concise access to N9-mono-, N2-mono- and N2,N9-di-substituted guanines via efficient Mitsunobu reactions
2010
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
2016
Direct Targeting Options for STAT3 and STAT5 in Cancer
2019